search

The support offered by Transnational Access comprises wet-lab and/or large-scale genomics data analysis. Costs of external user projects for consumables and for personnel required at the facilities will be fully covered by EASI-Genomics.

EASI-Genomics invites external users to apply for access by opening several calls for proposals. Interested users can submit proposals online using EASI-Genomics’ website. Proposals will be evaluated for scientific quality and impact, as well as eligibility and feasibility. EASI-Genomics recommends external users to contact the facilities offering the services of interest in order to discuss the feasibility of the submitted project prior to the submission of proposal. EASI-Genomics will launch four calls for proposal with a total budget of 6 million € (guidance average 40,000 per project).

Proposals will be handled confidentially.

Topics of the 1st Call for proposal:

  1. Sequencing of ancient DNA. Amongst others, applicants shall explicitly describe the status of immediately available sample material, and wet-lab and/or computational procedures required for support.
  2. Microbiome analyses of population-based and disease cohorts. Applicants shall explicitly describe the scientific value and quality control of the sample cohort(s). Wet-lab and/or computational procedures required for support shall be specified.
  3. Single-cell genomics. Amongst others, applicants shall describe what samples are available at EASI-Genomics facilities. Procedures required for wet lab and/or for data analysis support shall be clearly described.
  4. Identification of epigenetic signatures in human disease. Studies with samples derived from blood or analysing surrogate epigenetic markers are not eligible. Applicants shall instead focus on specific tissues/cell types to decipher epigenetic signatures with mechanistic relevance to disease. Applicants must specify available samples. Procedures required for wet lab and/or for data analysis support shall be clearly described.
  5. DNA and chromatin alterations: Applicants shall focus on mechanistically studying DNA and chromatin architecture alterations relevant to disease. For example, this can include analysis of the effect of structural variation or other functional analyses. Applicants shall explicitly describe the relevance of immediately available sample material required for disease-relevant and mechanistic analyses. Applicants shall specify wet-lab and/or computational procedures required for support.
  6. Sequence analysis of species of ecological and economic relevance using de novo sequence assembly and annotation. Applicants shall describe available samples including their economical relevance, and procedures required for wet lab and data analysis support.
  7. Data analysis. EASI-Genomics can provide data analysis for already existing data sets. Applicants should describe available data including sequencing technology used to generate it and the objective of the analysis. EASI-Genomics will provide state of the art bioinformatics support.

Read more

High performance computing (EuroHPC) calls for proposals now open

14-08-2019

The European High-Perfomance Computing Joint Undertaking (EuroHPC JU) pools European resources to develop top-of-the-range exascale supercomputers for processing big data, based on competitive European technology.
Read more

Horizon Europe Co-design – Implementation

02-08-2019

With a proposed budget of 100 billion euro from 2021 to 2027, the Horizon Europe framework programme represents the largest collaborative multinational research and innovation investment in Europe and is open to participants worldwide.
Read more

Call for Entries: ILUCIDARE Special Prizes funded by H2020

23-07-2019

Europa Nostra, the leading heritage network in Europe, and the European Commission have recently launched the Call for Entries to the European Heritage Awards/Europa Nostra Awards 2020.
Read more

2019 EU Innovation Scoreboard: Luxembourg is a “Strong innovator”

03-07-2019

The European Commission has recently published the 2019 edition of the European Innovation Scoreboard (EIS).
Read more

European Innovation Council to invest in high potential breakthrough innovation

03-07-2019

Innovators have a harder time finding risk-willing growth capital in Europe than in the US or in Asia. In order to alleviate this problem and pave the way for breakthrough and disruptive innovation, the European Innovation Council (EIC) has been set up as a new instrument aimed at providing substantial financial support to innovative researchers and companies. On 27 June 2019, Luxinnovation hosted an event where the EIC presented its new funding measures to Luxembourg stakeholders.
Read more

All news

Close